Ceapro Inc
XTSX:CZO

Watchlist Manager
Ceapro Inc Logo
Ceapro Inc
XTSX:CZO
Watchlist
Price: 5.99 CAD 0.5% Market Closed
Market Cap: 18.3m CAD
Have any thoughts about
Ceapro Inc?
Write Note

Ceapro Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ceapro Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Ceapro Inc
XTSX:CZO
Depreciation & Amortization
CA$1.9m
CAGR 3-Years
2%
CAGR 5-Years
27%
CAGR 10-Years
21%
Burcon NutraScience Corp
TSX:BU
Depreciation & Amortization
CA$312.8k
CAGR 3-Years
34%
CAGR 5-Years
39%
CAGR 10-Years
8%
EcoSynthetix Inc
TSX:ECO
Depreciation & Amortization
$1.1m
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
-5%
5N Plus Inc
TSX:VNP
Depreciation & Amortization
$16.4m
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
4%
Neo Performance Materials Inc
TSX:NEO
Depreciation & Amortization
$15.7m
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Ceapro Inc
Glance View

Market Cap
18.3m CAD
Industry
Chemicals

Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.

CZO Intrinsic Value
7.9 CAD
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Ceapro Inc's Depreciation & Amortization?
Depreciation & Amortization
1.9m CAD

Based on the financial report for Dec 31, 2023, Ceapro Inc's Depreciation & Amortization amounts to 1.9m CAD.

What is Ceapro Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
21%

Over the last year, the Depreciation & Amortization growth was 2%. The average annual Depreciation & Amortization growth rates for Ceapro Inc have been 2% over the past three years , 27% over the past five years , and 21% over the past ten years .

Back to Top